← All trials

NCT00277810

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Mar 1, 2006
Primary completion
Jun 1, 2008
Completion date
Jun 1, 2008
First posted
Last posted
Enrollment
250
Arms / groups
3 / —
Source
AACT · pre-existing

Sponsors

  • PfizerLead sponsor
  • WyethOverall official - principal investigator
  • WyethStudy director

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.